Torrent Pharmaceuticals has informed that a meeting of the Board of Directors will be held on Friday, 07-Nov-25, to consider and approve the Audited Financial Results on Standalone basis and Unaudited Financial Results (with limited review) on Consolidated basis of the Company for the quarter and half year ended on 30-Sep-25.
The above information is a part of company’s filings submitted to BSE.